Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endari in type 2 diabetes mellitus
NCT03947879Phase 1Unknown
- Sponsor
- Hawaii Pacific Health
- Start
- May 2019
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of glutamine in type 2 diabetes mellitus (T2DM), sponsored by Hawaii Pacific Health. Primary endpoints: Change in fasting glucose at 6 months and Change in hemoglobin A1c at 6 months. Status: unknown.
02
Drugs
glutamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03947879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03947879.